Skip to main content

E-learning | Real-life experience with biosimilars in multiple sclerosis

E-learning | Real-life experience with biosimilars in multiple sclerosis

Explore the scientific and clinical aspects of biosimilars in Multiple Sclerosis, with expert insights into regulatory frameworks, real-world evidence, and practical strategies for integrating biosimilars into patient care.

Biosimilars are becoming increasingly relevant in Multiple Sclerosis (MS) treatment, offering new opportunities for clinical practice. But how can healthcare professionals confidently integrate them into routine care?

This e-learning provides practical insights into biosimilar natalizumab, covering regulatory approval, clinical evidence, switching strategies, safety monitoring, and patient communication to support informed treatment decisions.

Access the e-learning

What does this e-learning include?

  • Expert presentations on the scientific and regulatory foundations of biosimilars in MS.
  • Real-world insights into switching strategies, safety monitoring, and patient management.
  • A dedicated Q&A session addressing practical clinical questions.
  • A final assessment and ParadigMS Certificate upon completion.

Experts: Jelena Drulovic and Tjalf Ziemssen
Certification: Certified by Paradigms Foundation
Duration: 1 learning hour
Access: Free for healthcare professionals

Media

Details

  • Directors

    Paradigms Foundation

  • Author(s)

    Jelena Drulovic and Tjalf Ziemssen

  • Country

    Serbia and Germany

  • Release Date

    October 30, 2026

  • Views

    Views: 15

We value your opinion.

Selected Value: 1
Give a score from 1 (= not at all likely) to 10 (extremely likely)
Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.
If you have submitted a question above, leave your email so we can get back to you.

You Might Also Like

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.